Clinical Trial Detail

NCT ID NCT04372927
Title ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

lung non-small cell carcinoma

Therapies

Cisplatin + Durvalumab + Pemetrexed Disodium

Cisplatin + Durvalumab + Etoposide

Age Groups: adult senior

No variant requirements are available.